Abstract
Background
Anatomic resection with lymph node dissection or sampling is the standard treatment for early non-small cell lung cancer (NSCLC), and wedge resection is an option for compromised patients. This study aimed to determine whether wedge resection can provide comparable prognoses for elderly patients with NSCLC.
Methods
The study analyzed the clinicopathologic findings and surgical outcomes during a median follow-up period of 39.6 months for 156 patients with solid dominant (consolidation-to-tumor ratio > 0.5) small (whole tumor size ≤ 2 cm) NSCLC among 892 patients 80 years of age or older with medically operable lung cancer between April 2015 and December 2016.
Results
The 3-year overall survival (OS) rates after wedge resection and after segmentectomy plus lobectomy did not differ significantly (86.5 %; 95 % confidence interval [CI], 74.6–93.0 % vs 83.7 % 95 % CI, 74.0–90.0 %; P = 0.92). Multivariable Cox regression analysis of OS with propensity scores showed that the surgical procedure was not an independent prognostic predictor (hazard ratio [HR], 0.84; 95 % CI, 0.39–1.8; P = 0.64). The 3-year OS rates were slightly better after wedge resection for 97 patients who could tolerate lobectomy than after segmentectomy plus lobectomy (89.4 %; 95 % CI, 73.8–95.9 % vs 75.8 %; 95 % CI, 62.0–85.2 %; P = 0.14). The cumulative incidence of other causes for death was marginally higher after segmentectomy plus lobectomy than after wedge resection (P = 0.079).
Conclusions
Wedge resection might be equivalent to lobectomy or segmentectomy for selected patients 80 years of age or older with early-stage NSCLC who can tolerate lobectomy.
Similar content being viewed by others
References
Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata T, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40:271–4.
Kohman LJ, Gu L, Altorki N, Scalzetti E, Veit LJ, Wallen JM, et al. Biopsy first: lessons learned from Cancer and Leukemia Group B (CALGB) 140503. J Thorac Cardiovasc Surg. 2017;153:1592–7.
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615–22 (discussion 22–3).
Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141:662–70.
Okada M, Yoshikawa K, Hatta T, Tsubota N. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg. 2001;71:956–60 (discussion 61).
Okami J, Shintani Y, Okumura M, Ito H, Ohtsuka T, Toyooka S, et al. Demographics, safety and quality, and prognostic information in both the seventh and eighth editions of the TNM Classification in 18,973 surgical cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010. J Thorac Oncol. 2019;14:212–22.
Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol. 2009;4:1247–53.
Mimae T, Miyata Y, Tsutani Y, Imai K, Ito H, Nakayama H, et al. Wedge resection as an alternative treatment for octogenarian and older patients with early-stage non-small cell lung cancer. Jpn J Clin Oncol. 2020;50:1051–7.
Saji H, Ueno T, Nakamura H. Prospective observational cohort study of postoperative risk and prognosis scoring for elderly patients with medically operable lung cancer (JACS1303). Gen Thorac Cardiovasc Surg. 2016;64:634–5.
Saji H, Ueno T, Nakamura H, Okumura N, Tsuchida M, Sonobe M, et al. A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303. Eur J Cardiothorac Surg. 2018;53:835–41.
Travis WDBE, Burke AP, Marx A, Nicholson AG. WHO Classification of tumours of the lung, pleura, thymus and heart. 4th edn. Lyon, France: International Agency for Research on Cancer; 2015.
TNM Classification of Malignant Tumours. 7th ed. Wiley-Blackwell, Oxford, UK, 2009.
Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG Jr. Resuscitation: how do we decide? A prospective study of physicians’ preferences and the clinical course of hospitalized patients. JAMA. 1986;255:1316–22.
Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transp. 2013;48:452–8.
Linden PA, D’Amico TA, Perry Y, Saha-Chaudhuri P, Sheng S, Kim S, et al. Quantifying the safety benefits of wedge resection: a Society of Thoracic Surgery database propensity-matched analysis. Ann Thorac Surg. 2014;98:1705–11 (discussion 11–2).
Mimae T, Tsutani Y, Miyata Y, Imai K, Ito H, Nakayama H, et al. Solid tumor size of 2 cm divides outcomes of patients with mixed ground-glass-opacity lung tumors. Ann Thorac Surg. 2020;109:1530–6.
Acknowledgments
This study was supported by a Grant-in-Aid from the Committee for Scientific Affairs, The Japanese Association for Chest Surgery, Kyoto, Japan and by grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI (20K09177). The language in this report was proof-checked by a native English speaker with more than 25 years of experience in professionally editing medical manuscripts.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Keiju Aokage gave lecture presentations for Mochida Pharmaceutical Co., Ltd, Astrazeneca, Covidien Japan, Taiho Parma, Bristol Myers Squibb, and Eli Lilly; gave seminar presentations for MSD; and did writing for Taiho Parma and Care-net.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mimae, T., Saji, H., Nakamura, H. et al. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303. Ann Surg Oncol 28, 7219–7227 (2021). https://doi.org/10.1245/s10434-021-09835-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-09835-w